AzTrials
AzTrials

Chronic PainNCT04689646

Mind Body Syndrome Therapy for Chronic Pain

A study testing Mind Body Intervention 1 and Mind body intervention 2 in people with Chronic Pain and Chronic Pain Syndrome, run by Beth Israel Deaconess Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to… Read more about this study

Who is it for?
Ages 18 to 67 years
Conditions the study is for
Chronic Pain, Chronic Pain Syndrome
What is being tested?
Mind Body Intervention 1 and Mind body intervention 2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
126 participants
Where
1 siteUnited States
Study dates
20 May 2021to 6 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 67 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient 18 ≥ years old
  • Chronic back pain
  • Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment
  • Willingness to consider mind-body intervention
  • At least score of 2 or more on Roland Disability Questionnaire
  • At least score of 3 or more back pain bothersomeness

Who cannot join

  • Patients < 18 years of age
  • Patients > 67 years of age
  • Diagnosed organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome (note that pain related to disc disease is not an exclusion unless there are neurological impairments)
  • Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia, and bipolar disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: Mind Body Syndrome Therapy for the Treatment of Chronic Pain

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Read the detailed description

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care (control arm) and an active control arm. The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Being tested
Mind Body Intervention 1, Mind body intervention 2
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mind Body Intervention 1Behavioural

    Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

  • Mind body intervention 2Behavioural

    Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

Study groups in NCT04689646
Study groupRoleWhat they receive
Mind-Body Intervention 1ExperimentalParticipants will receive a mind body educational based intervention to learn the techniques comprising intervention 1.
Receives: Behavioral: Mind Body Intervention 1
Mind-Body Intervention 2Active comparatorParticipants will receive a mind body educational based intervention to learn the techniques comprising intervention 2.
Receives: Behavioral: Mind body intervention 2
Usual CareNo interventionParticipants will continue their usual care for 26 weeks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Disability

    Roland Morris Disability Index (Scale 0-24 with 24 being worst)

    Measured: 26 weeks

Secondary outcomes (6)
  1. Average pain

    Average pain as determined in the Brief Pain Inventory Survey (Scale 0-10 with 10 being worst)

    Measured: Baseline, 4, 8, 13, and 26 weeks after initiation of the study.

  2. Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey

    Back pain bothersomeness as determined from modified Brief Pain Inventory Survey. (Scale 0-10 with 10 being the worst

    Measured: Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks

  3. Anxiety from pain

    Anxiety from pain as determined from the Pain Anxiety Symptom Scale-20 survey (20 questions with scale of 0-5 with 5 being 'always' and 0 being 'never'

    Measured: Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks

  4. Resolution of pain disability

    Resolution of pain disability as measured by 0 or 1 on Roland Morris Disability (Scale 0-24 with 24 being worst)

    Measured: Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks

  5. Pain affecting enjoyment of life

    Scale 0-10 with 10 being worst from Brief Pain Inventory

    Measured: Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks

  6. Resolution of back pain bothersomeness

    Resolution of back pain bothersomeness as measured as 0-1 on scale 0-10

    Measured: Baseline, 4 weeks, 8 weeks, 13 weeks, 26 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2020
  2. Study start20 May 2021
  3. Primary completion6 Jul 2026
  4. Study completion6 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Mind-Body Intervention 1, Mind-Body Intervention 2 and Usual Care
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04689646
Sponsor's protocol ID
2020P000147
Status last verified
Sep 2026
First submitted
27 Dec 2020
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mind Body Intervention 1 and Mind body intervention 2 in people with Chronic Pain and Chronic Pain Syndrome, run by Beth Israel Deaconess Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Disability (time frame: 26 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in